Leadership Overview
Rho has 8 executives leading key functions including strategy, operations, revenue, finance, technology, medical affairs, and corporate leadership.
Driven by a commitment to advancing drug development, Rho provides comprehensive clinical research services across the entire drug development process, impacting global health outcomes.
Driven by a commitment to advancing drug development, Rho provides comprehensive clinical research services across the entire drug development process, impacting global health outcomes.
Leadership Roles at Rho
Lawrence Morentz - Chief Executive Officer
Lawrence Morentz, the Chief Executive Officer at Rho, directs the overarching corporate strategy and operational framework. Morentz guides the organization's expansion within the contract research sector, ensuring alignment with market demands for comprehensive drug development services. This leadership role involves fostering innovation in clinical trial management and maintaining Rho's position as a key partner for pharmaceutical and biotechnology firms. By focusing on strategic partnerships and long-term growth initiatives, Lawrence Morentz drives the company's mission to accelerate therapeutic advancements. The Chief Executive Officer's purview encompasses all facets of the business, from research and development oversight to client relations and financial planning, ensuring sustained market leadership and operational excellence.
Francis Wall - Chief Financial Officer
Francis Wall, the Chief Financial Officer at Rho, directs all financial planning, accounting, and reporting functions for the organization. Wall manages the company's fiscal health, overseeing budgeting, forecasting, and investment strategies to support Rho's growth and operational stability. This critical role involves ensuring financial compliance, managing capital allocation, and providing strategic financial insights to leadership. By maintaining rigorous financial controls and optimizing capital structure, Francis Wall safeguards the company's assets and enhances shareholder value. The Chief Financial Officer's purview includes risk management, treasury operations, and driving financial performance to meet strategic business goals.
Alena Hammond - Chief Operating Officer
Alena Hammond, the Chief Operating Officer at Rho, oversees the day-to-day operational execution and efficiency across all clinical research services. Hammond manages the complex logistics of clinical trials, ensuring adherence to regulatory standards and optimizing resource allocation for project success. This role involves direct supervision of operational departments, driving process improvements, and implementing best practices in data management and patient recruitment strategies. By focusing on operational excellence, Alena Hammond ensures that Rho delivers high-quality research outcomes for its clients. The Chief Operating Officer's responsibilities extend to managing cross-functional teams, enhancing service delivery capabilities, and supporting the company's growth objectives through robust operational frameworks.
Deborah Johnson - President
Deborah Johnson, the President at Rho, plays a pivotal role in shaping the company's strategic direction and operational execution. Johnson oversees key business functions, ensuring seamless integration of services and driving initiatives that enhance Rho's market presence. This leadership capacity involves fostering a culture of excellence and accountability across departments, contributing to the company's overall success. By focusing on strategic growth and operational efficiency, Deborah Johnson supports Rho's mission to advance drug development. The President's responsibilities extend to stakeholder engagement and ensuring the company consistently meets its objectives.
Mary Helms - President & Co-Founder
Mary Helms, the President & Co-Founder at Rho, provides foundational leadership and strategic vision for the organization. Helms has been instrumental in establishing Rho's core values and guiding its growth since its inception. This role involves overseeing strategic partnerships and ensuring the company's long-term vision is realized through effective operational management. By championing innovation and client-centric approaches, Mary Helms reinforces Rho's commitment to excellence in clinical research. The President & Co-Founder's influence shapes the company's culture and strategic trajectory, ensuring sustained success and impact in the drug development landscape.
Thomas McNulty - Chief Revenue Officer
Thomas McNulty, the Chief Revenue Officer at Rho, spearheads all revenue generation activities and client acquisition strategies. McNulty directs the sales and business development teams, cultivating relationships with pharmaceutical and biotech companies seeking clinical research support. This leadership position involves identifying new market opportunities, expanding service offerings, and ensuring revenue growth aligns with corporate objectives. By focusing on strategic client engagement and market penetration, Thomas McNulty drives the commercial success of Rho. The Chief Revenue Officer's responsibilities include developing pricing strategies, managing the sales pipeline, and fostering long-term partnerships that contribute to sustained financial performance and market expansion.
Biljana Djordjevic - Technology Chief of Staff
Biljana Djordjevic, the Technology Chief of Staff at Rho, supports the strategic direction and execution of technology initiatives across the organization. Djordjevic collaborates with technology leadership to align IT infrastructure with business objectives, ensuring efficient and secure operations. This role involves facilitating cross-departmental communication, managing technology projects, and driving innovation in digital solutions for clinical research. By enhancing technological capabilities, Biljana Djordjevic contributes to Rho's ability to deliver cutting-edge services. The Technology Chief of Staff's responsibilities include optimizing technology investments, improving system performance, and supporting the digital transformation efforts critical to the company's competitive edge.
Andrew Feigin - Chief Medical Officer
Andrew Feigin, the Chief Medical Officer at Rho, provides critical medical and scientific leadership for all clinical research programs. Feigin guides the design and execution of clinical trials, ensuring scientific rigor and patient safety are paramount throughout the drug development process. This role involves overseeing medical monitoring, interpreting clinical data, and advising clients on therapeutic strategies. By leveraging extensive medical expertise, Andrew Feigin ensures the integrity and success of Rho's research endeavors. The Chief Medical Officer's responsibilities include contributing to regulatory submissions, advancing scientific understanding, and maintaining the highest standards of clinical practice.
Explore Leadership Teams in Business Services
SGS is an inspection, verification, testing, and certification company. The company inspects agricultural products, minerals, petroleum and petrochemicals, motor vehicles, and consumer goods. SGS is headquartered in Geneva, Switzerland.
Company Leadership SP
SN
SK
HN
The Urban Institute operates as a nonpartisan research organization committed to generating rigorous analysis and evidence-based insights on critical social and economic policy questions. Through empirical research and data-driven investigation, the organization works to inform public discourse and guide policymakers toward solutions that address complex societal challenges. The institute's work spans multiple dimensions of policy analysis, examining issues that directly affect communities and individuals across diverse socioeconomic circumstances. The organization maintains a multidisciplinary approach to research, bringing together economists, social scientists, and policy experts who collaborate to produce comprehensive studies and evaluations. This collaborative model enables the institute to examine interconnected policy challenges from multiple perspectives, generating nuanced findings that reflect the complexity of real-world problems. The research teams conduct original data collection, statistical analysis, and longitudinal studies designed to track outcomes and measure the effectiveness of various policy interventions. Urban Institute research addresses a broad spectrum of policy domains, including economic opportunity, education systems, health care access, housing markets, and government effectiveness.
Company Leadership MA
YK
Altasciences Inc is a contract research organization. It provides preclinical and clinical services, manufacturing and analytical services, bioanalytical, and CRO services. The company was formed in 1992 and is based in Laval, Canada.
Company Leadership SM
JW
Velocity Clinical Research, headquartered in Durham, NC, is a leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies.
Company Leadership GC
Frequently Asked Questions Regarding Rho Top Executives and Leadership Team
